Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Advances in Therapy|November 21, 2018
An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in DenmarkRichard F Pollock, Gorden MudumaExpert Review of Hematology|January 29, 2019
A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatmentRichard F Pollock, Gorden MudumaClinicoeconomics and Outcomes Research : CEOR|January 14, 2021
An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and FinlandRichard F Pollock, Gorden MudumaClinicoeconomics and Outcomes Research : CEOR|August 30, 2017
A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000Richard F Pollock, Gorden MudumaJournal of Medical Economics|March 26, 2020
A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United KingdomRichard F Pollock, Gorden MudumaJournal of Medical Economics|May 13, 2016
A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UKGorden Muduma, Isaac Odeyemi, Richard F PollockAdvances in Therapy|February 8, 2020
Development of a Resource Impact Model for Clinics Treating Pre-Operative Iron Deficiency Anemia in IrelandFrank Loughnane, Gorden Muduma, Richard F PollockDrugs - Real World Outcomes|October 18, 2016
Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical PracticeGorden Muduma, Isaac Odeyemi, Richard Fulton PollockJournal of Medical Economics|April 24, 2014
A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variabilityGorden Muduma, Isaac Odeyemi, Richard F PollockPlos One|November 5, 2016
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver TransplantGorden Muduma, Rhodri Saunders, Isaac Odeyemi, et al.Pageof 2